| |
| |
|
| Insider
Information: |
Ford Brendan A |
| Relationship: |
Director |
| City: |
Dublin |
| State: |
OH |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
325,928 |
|
|
Indirect Shares
|
16,217 |
|
|
| Direct
Value |
$8,553,589 |
|
|
|
Indirect Value
|
$1,606,780 |
|
|
| Total
Shares |
342,145 |
|
|
| Total
Value |
$10,160,369 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cardinal Health Inc |
CAH |
EVP-Corporate Developm... |
2006-09-02 |
85,978 |
2006-09-02 |
16,217 |
Premium* |
|
|
Navidea Biopharmaceuticals |
NAVB |
Director |
2015-07-31 |
239,950 |
2010-11-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
33 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CAH |
Cardinal Health Inc |
EVP - Corp. Development |
• – – |
2003-10-13 |
4 |
OE |
$10.25 |
$173,019 |
D/D |
16,875 |
52,805 |
|
- |
|
| CAH |
Cardinal Health Inc |
EVP - Corp. Development |
• – – |
2004-02-23 |
4 |
OE |
$11.43 |
$138,911 |
D/D |
12,150 |
64,955 |
|
- |
|
| CAH |
Cardinal Health Inc |
EVP - Corp. Development |
• – – |
2004-02-23 |
4 |
S |
$63.71 |
$1,083,396 |
D/D |
(17,000) |
47,955 |
|
- |
|
| CAH |
Cardinal Health Inc |
EVP - Corp. Development |
• – – |
2004-08-02 |
4 |
B |
$43.77 |
$1,751 |
D/D |
40 |
59,995 |
2.66 |
- |
|
| CAH |
Cardinal Health Inc |
EVP - Corp. Development |
• – – |
2004-08-06 |
4 |
A |
$0.00 |
$0 |
D/D |
12,000 |
59,955 |
|
- |
|
| CAH |
Cardinal Health Inc |
EVP - Corp. Development |
• – – |
2005-02-03 |
4 |
OE |
$14.67 |
$148,503 |
D/D |
10,125 |
70,120 |
|
- |
|
| CAH |
Cardinal Health Inc |
EVP - Corp. Development |
• – – |
2005-02-03 |
4 |
AS |
$60.00 |
$375,480 |
D/D |
(6,258) |
63,862 |
|
- |
|
| CAH |
Cardinal Health Inc |
EVP |
• – – |
2005-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
68,862 |
|
- |
|
| CAH |
Cardinal Health Inc |
EVP |
• – – |
2005-09-02 |
4 |
A |
$0.00 |
$0 |
D/D |
7,679 |
76,541 |
|
- |
|
| CAH |
Cardinal Health Inc |
officerTitle |
• – – |
2005-12-29 |
4 |
D |
$65.86 |
$10,603 |
D/D |
(161) |
76,380 |
|
- |
|
| CAH |
Cardinal Health Inc |
officerTitle |
• – – |
2006-01-31 |
4 |
OE |
$17.74 |
$239,490 |
D/D |
13,500 |
89,880 |
|
- |
|
| CAH |
Cardinal Health Inc |
officerTitle |
• – – |
2006-01-31 |
4 |
D |
$72.52 |
$579,145 |
D/D |
(7,986) |
81,894 |
|
- |
|
| CAH |
Cardinal Health Inc |
EVP-Corporate Development |
• – – |
2006-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
6,874 |
87,052 |
|
- |
|
| CAH |
Cardinal Health Inc |
EVP-Corporate Development |
• – – |
2006-08-18 |
4 |
OE |
$27.05 |
$279,999 |
D/D |
10,350 |
97,402 |
|
- |
|
| CAH |
Cardinal Health Inc |
EVP-Corporate Development |
• – – |
2006-08-18 |
4 |
S |
$67.47 |
$598,078 |
D/D |
(8,850) |
88,552 |
|
- |
|
| CAH |
Cardinal Health Inc |
EVP-Corporate Development |
• – – |
2006-08-21 |
4 |
S |
$67.61 |
$101,418 |
D/D |
(1,500) |
87,052 |
|
- |
|
| CAH |
Cardinal Health Inc |
EVP-Corporate Development |
• – – |
2006-09-02 |
4 |
D |
$68.02 |
$73,053 |
D/D |
(1,074) |
85,978 |
|
- |
|
| NAVB |
Navidea Biopharmaceutical... |
Director |
– • – |
2010-11-15 |
4 |
B |
$1.73 |
$52,575 |
D/D |
30,000 |
30,000 |
2.39 |
- |
|
| NAVB |
Navidea Biopharmaceutical... |
Director |
– • – |
2011-08-19 |
4 |
B |
$2.51 |
$50,200 |
D/D |
20,000 |
50,000 |
2.39 |
- |
|
| NAVB |
Navidea Biopharmaceutical... |
Director |
– • – |
2012-04-10 |
4 |
A |
$0.00 |
$0 |
D/D |
17,000 |
67,000 |
0 |
- |
|
| NAVB |
Navidea Biopharmaceutical... |
Director |
• • – |
2012-09-12 |
4 |
B |
$2.64 |
$13,200 |
D/D |
5,000 |
72,000 |
2.81 |
- |
|
| NAVB |
Navidea Biopharmaceutical... |
Director |
• • – |
2013-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
12,250 |
84,250 |
0 |
- |
|
| NAVB |
Navidea Biopharmaceutical... |
Director |
• • – |
2013-03-13 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
114,250 |
0 |
- |
|
| NAVB |
Navidea Biopharmaceutical... |
Director |
– • – |
2013-03-15 |
4 |
B |
$2.71 |
$13,550 |
D/D |
5,000 |
119,250 |
2.39 |
- |
|
| NAVB |
Navidea Biopharmaceutical... |
Director |
• • – |
2013-11-08 |
4 |
B |
$1.45 |
$29,000 |
D/D |
20,000 |
139,250 |
2.39 |
- |
|
33 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
